2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
PSG Position: Copay Accumulators
When it comes to copay accumulators,patient impact – not final rule – should drive plan sponsor’s strategy As additional guidance is provided, we’ll continue…
Read Post
Three Proactive Strategies for Reducing Waste in Your Plan’s Formulary
Drug cost management is a top priority for plan sponsors. It’s no wonder, then, that the concept of eliminating waste from plan formularies has…
Read Post
The Hidden Costs of Non-Essential Drugs in Your Plan’s Formulary
Plan sponsors are constantly waging a war on unnecessary drug spend and waste due to the inclusion of non-essential drugs on their PBM’s formulary or…
Read Post
PSG Cares – Our Community Involvement
PSG recognizes our responsibility as good corporate citizens is, in part, to help enrich our surrounding areas of residence and work by positively impacting…
Read Post
PBM Satisfaction Still Important After 24 Years
Customer satisfaction in the business-to-business (B2B) world is essential to company success. The stakes are particularly high in areas like pharmacy benefit managers (PBMs).
Read Post
Partnering with Your PBM to Reduce Drug Benefit Costs for Health-System Employees
As both consumers and providers of healthcare services, hospitals and health systems have a unique ability to lower pharmaceutical costs for their employees while…
Read Post
Drug Rebates vs. Lowest Net Cost: Why It Matters for Your PBM Procurements
For years, rebates have been a dominant factor in the drug pricing equation for plan sponsors. To maintain affordability, employers have had to accept a…
Read Post
Highlights from the 2019 PBMI Trends in Specialty Drug Benefits Report: Why Specialty Drug Cost-Sharing Is a Balancing Act for Plan Sponsors
For the past eight years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug benefit designs used by employers,…
Read Post
Seize the Day: 4 Reasons to Pursue a PBM Procurement in 2019
The prescription drug market is changing yet again, creating an ideal opportunity for plan sponsors to evaluate vendor options for pharmacy benefit management (PBM).
Read Post
Highlights from the 2019 PBMI Trends in Specialty Drug Benefits Report: Specialty Drug Benefits by the Numbers
For the last eight years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug benefit designs used by employers,…
Read Post
What You Need to Know About The Drug Rebate Economy
Drug rebates are big business. According to life sciences analytics firm IQVIA, pharmaceutical manufacturers offered $153 billion in rebates and discounts in 2017. That’s…
Read Post